Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",21405,190,1.23 [0.99-1.52],0.0668193544571127
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",22590,243,1.05 [0.86-1.28],0.6375437207557076
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22316,1722,1.14 [1.06-1.23],0.0004056970274467
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Candidiasis,22596,530,1.20 [1.05-1.36],0.0071925547519969
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,21851,4132,1.14 [1.09-1.20],7.690242156479908e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),21797,4217,1.11 [1.06-1.17],1.0692594280620992e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,22311,1393,1.14 [1.05-1.23],0.0025548220307252
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,22502,128,0.91 [0.68-1.21],0.5122679825377348
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,19829,1266,1.21 [1.11-1.32],1.4119138771070938e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19135,1546,1.20 [1.11-1.29],6.634056201908011e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,18644,328,1.25 [1.06-1.47],0.0089570836355233
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,14698,2680,1.11 [1.05-1.19],0.0005124709209605
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,18592,486,1.30 [1.14-1.49],0.0001119557657477
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22571,1653,1.13 [1.04-1.22],0.0020087421180906
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Mycoses,22686,620,1.23 [1.09-1.38],0.0009213128440886
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,21813,1219,1.12 [1.03-1.23],0.0107153900417754
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,22614,1399,1.18 [1.09-1.28],5.352592175625215e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,21161,243,1.06 [0.86-1.29],0.5863365788980245
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,22744,64,0.99 [0.66-1.47],0.9469278555287086
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22437,1222,1.18 [1.08-1.29],0.0001930361121015
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,22449,75,1.40 [1.01-1.94],0.0450054339012544
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other viral diseases,22681,136,1.29 [1.00-1.66],0.0490433714788624
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",22660,115,1.21 [0.91-1.60],0.1824750995973524
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21087,493,1.16 [1.01-1.33],0.0341483077610507
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,20895,301,1.17 [0.99-1.40],0.0733104903960049
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,21053,135,1.33 [1.03-1.71],0.0259416629777097
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,22729,51,0.86 [0.54-1.36],0.5201279654843924
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,22675,168,1.07 [0.84-1.36],0.6094651791851815
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Viral warts,22560,53,1.48 [1.02-2.16],0.0415964896939624
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],22584,77,0.90 [0.62-1.31],0.5944073997377805
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign lipomatous neoplasm,22454,261,0.93 [0.76-1.13],0.4644963557881126
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,22662,40,0.93 [0.56-1.55],0.7888808710003365
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,22645,44,1.05 [0.65-1.68],0.8551338308759139
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,10850,84,1.08 [0.77-1.51],0.6591027146450568
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22295,1635,0.98 [0.90-1.06],0.5862934347542725
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm of meninges,22729,64,1.37 [0.96-1.95],0.0849699767699581
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,22648,79,1.25 [0.90-1.75],0.1849483002647554
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,22717,117,1.33 [1.02-1.74],0.0367485964169254
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm of ovary,11826,78,0.75 [0.51-1.10],0.1421675923436091
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Ascending colon,22706,430,1.05 [0.91-1.23],0.4942083697812023
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Caecum,22710,377,0.95 [0.80-1.12],0.544890694723658
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",22602,85,0.86 [0.60-1.23],0.4064606038425461
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Descending colon,22701,248,1.06 [0.87-1.30],0.5385219021423254
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Rectum,22662,402,0.98 [0.83-1.15],0.7949481895609044
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,22597,652,0.95 [0.84-1.08],0.4184218368919552
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Transverse colon,22688,525,0.97 [0.85-1.12],0.7065956957699135
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Carcinoma in situ of breast,8895,49,0.92 [0.58-1.48],0.7404384862026283
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",8935,64,1.11 [0.75-1.64],0.5951710880406701
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",16237,71,1.21 [0.84-1.73],0.3004467777211136
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",16263,97,1.04 [0.75-1.44],0.799740549543522
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",22688,124,1.12 [0.85-1.48],0.4356662369182658
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Haemangioma, any site",22689,121,1.05 [0.79-1.40],0.7478693948052471
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Leiomyoma of uterus,11560,165,0.94 [0.73-1.21],0.6552885248011242
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Lung cancer and mesothelioma,14378,471,1.24 [1.08-1.43],0.002630166868624
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Lymphoid leukaemia,16239,73,1.37 [0.98-1.91],0.0691419322396114
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16387,221,1.07 [0.87-1.33],0.5224620851215936
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",16478,312,0.97 [0.81-1.17],0.7394909769400762
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",9015,102,0.82 [0.59-1.14],0.2365083833345733
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",16271,105,1.20 [0.89-1.62],0.2198564980889569
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",16311,145,1.32 [1.04-1.69],0.0252903374327333
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",16290,124,0.90 [0.67-1.21],0.4970548234400695
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",8996,83,1.05 [0.74-1.48],0.800261604568641
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",16291,125,1.12 [0.85-1.48],0.4183352676438373
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",8206,953,1.02 [0.92-1.14],0.6677549028866785
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",16302,136,0.95 [0.72-1.26],0.7199565466334736
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",16256,90,1.50 [1.12-2.01],0.0071907993977042
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,16307,141,0.99 [0.76-1.30],0.954312646986585
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Melanocytic naevi,22601,179,0.94 [0.74-1.20],0.6255106479689851
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Melanocytic naevi of trunk,22716,76,1.03 [0.72-1.49],0.8550398789679851
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Melanoma in situ,16217,107,0.99 [0.72-1.35],0.9289936789056592
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",16283,117,1.03 [0.77-1.39],0.8262887460907922
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16360,194,1.08 [0.86-1.36],0.5040651101824634
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",16487,321,1.05 [0.88-1.25],0.5770259272785059
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",16290,124,1.14 [0.86-1.50],0.3743481005010083
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Other benign neoplasms of skin,22574,161,0.91 [0.70-1.18],0.470353745383813
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",17629,1463,1.00 [0.92-1.09],0.9989439896629628
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",17710,1544,1.01 [0.93-1.09],0.9047158084055672
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22439,384,1.04 [0.89-1.23],0.5944050959316657
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,20469,163,1.56 [1.26-1.93],3.6930315176056654e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22122,67,1.57 [1.13-2.19],0.006809641432277
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,21989,3427,1.14 [1.08-1.20],9.673297746024035e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,21050,70,1.22 [0.85-1.75],0.272530928843162
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,22288,62,0.98 [0.65-1.47],0.9179198261221546
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22243,1937,1.14 [1.06-1.22],0.0002203604148498
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22241,1935,1.14 [1.06-1.22],0.0002358235021019
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,20418,112,0.95 [0.70-1.29],0.7389571321279798
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22389,1409,1.36 [1.26-1.47],1.6971364722012405e-15
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,22332,106,0.94 [0.69-1.29],0.7062395911586943
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22132,77,0.94 [0.65-1.36],0.7442224011861407
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22130,75,0.81 [0.56-1.20],0.2960939587618949
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,22571,345,0.95 [0.80-1.13],0.5655578450634382
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,22618,39,0.97 [0.58-1.63],0.9217180792400936
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",22508,282,0.86 [0.70-1.04],0.1257025532909535
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,21115,135,1.27 [0.98-1.64],0.0672737593075993
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,15224,412,1.30 [1.12-1.51],0.0007406542504273
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21253,102,0.91 [0.66-1.25],0.5720653343752625
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21262,111,0.91 [0.66-1.25],0.5477186235896548
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,14881,69,0.95 [0.64-1.41],0.8116014350406533
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21118,64,1.30 [0.90-1.87],0.1646019493233699
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,20346,309,1.01 [0.84-1.21],0.9495255084327756
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",21953,938,1.09 [0.98-1.20],0.1099274858976462
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,21497,482,1.02 [0.89-1.19],0.7404863789578642
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,21231,216,1.31 [1.08-1.60],0.0070582742429618
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,22459,1405,1.23 [1.14-1.34],2.674507214060648e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,19124,1362,1.25 [1.15-1.36],5.40063890343644e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",14899,87,1.06 [0.76-1.50],0.7220935273086742
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",20482,99,1.15 [0.85-1.57],0.3570500370115995
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,15179,367,1.14 [0.97-1.35],0.1178205212425411
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,14865,53,0.79 [0.49-1.26],0.3139234644688363
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19307,4495,1.11 [1.05-1.16],2.9061757011623304e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,15074,262,1.18 [0.97-1.43],0.0912225316214847
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,15516,704,1.14 [1.01-1.28],0.0356104796165736
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,22687,365,1.18 [1.01-1.39],0.038786645632154
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,22482,160,1.31 [1.04-1.65],0.0238893050860957
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,14964,152,0.91 [0.69-1.19],0.4863765693375739
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",14894,82,1.18 [0.84-1.67],0.3406408317137059
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22110,1727,1.09 [1.01-1.17],0.032922786930572
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,15188,376,1.26 [1.08-1.48],0.004118238714219
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,15227,415,1.38 [1.19-1.59],2.307191433780864e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15660,848,1.08 [0.97-1.21],0.1486662196689255
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,14982,170,1.14 [0.89-1.46],0.2971867618116327
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,22472,150,1.25 [0.98-1.59],0.0749630778613412
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,15696,884,1.04 [0.93-1.16],0.5031985431678017
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,15459,647,1.08 [0.95-1.22],0.2556804716993502
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,20115,78,1.17 [0.83-1.66],0.3766268979014783
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21112,6300,1.09 [1.04-1.13],4.416569729670453e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,20442,59,0.85 [0.55-1.30],0.4481446781892855
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,20434,51,0.99 [0.63-1.54],0.9488905201224536
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,22560,1883,1.01 [0.94-1.09],0.7444108972429557
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22558,1881,1.01 [0.94-1.09],0.7608133539004259
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,20449,66,0.95 [0.64-1.41],0.795274917682155
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,22394,1127,1.09 [1.00-1.20],0.0626265875329558
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",17019,2207,1.13 [1.06-1.21],0.0002939439833735
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,22729,305,1.24 [1.05-1.47],0.0124596677290928
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,21144,129,1.23 [0.95-1.60],0.1207510775499276
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,21383,116,0.91 [0.67-1.23],0.5311786165003839
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,21429,162,1.22 [0.96-1.54],0.107574947398197
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",15009,197,1.09 [0.87-1.37],0.43419884734386
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,19984,176,1.51 [1.23-1.86],0.000110043185561
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2437,97,1.35 [0.99-1.85],0.0565900404804223
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2603,303,1.10 [0.92-1.33],0.2882621304803452
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,19892,84,1.55 [1.15-2.09],0.0042107820167394
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2413,76,1.11 [0.77-1.60],0.5815140265833951
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,21913,2105,1.34 [1.26-1.43],1.0416461355250013e-19
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,21638,623,1.06 [0.94-1.20],0.3545727239187732
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,20479,442,1.15 [1.00-1.33],0.0571999683013242
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,15907,1095,1.15 [1.05-1.27],0.0033667952119477
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",22609,298,0.99 [0.83-1.20],0.954258497136649
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),21265,265,1.21 [1.00-1.45],0.0464346630655296
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Angina pectoris,19643,1554,1.24 [1.15-1.33],4.5183906459253865e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Aortic aneurysm,21369,369,1.12 [0.96-1.32],0.1606760685525378
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,21084,84,1.22 [0.88-1.68],0.2388695199405807
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",21283,283,1.35 [1.14-1.60],0.0005616663627129
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11516,2793,1.04 [0.98-1.10],0.2151852893164746
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,AV-block,17286,660,1.16 [1.03-1.30],0.0166620759064106
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",22664,580,1.03 [0.90-1.18],0.6497369986599665
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Cardiac arrest,8984,261,1.19 [0.98-1.45],0.0770065549874445
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Cardiomyopathy,16822,196,1.05 [0.84-1.32],0.6405145874684035
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",16732,106,1.21 [0.90-1.62],0.1989317533348683
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,22740,79,1.06 [0.75-1.50],0.7439738083766168
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Conduction disorders,18143,1517,1.08 [0.99-1.17],0.0748527269536052
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,20778,2714,1.17 [1.11-1.24],1.0224533729551864e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18240,8741,1.04 [1.00-1.07],0.0298284358807483
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21196,328,1.02 [0.86-1.22],0.7966839271801303
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Endocarditis,16726,100,1.17 [0.87-1.59],0.3025221116334964
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22457,1633,1.21 [1.12-1.30],5.785141631821601e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypertension,19459,7782,1.06 [1.02-1.10],0.0015558216398557
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Hypertension, essential",19480,7803,1.06 [1.02-1.10],0.0012631347799266
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Hypertension, portal",22575,94,0.79 [0.56-1.12],0.1865694460632955
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",11934,257,1.48 [1.25-1.76],8.550872515248986e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,11882,205,1.84 [1.53-2.21],7.422565361527174e-11
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypotension,22563,1611,1.09 [1.01-1.18],0.0232828385015973
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,21471,142,1.00 [0.77-1.31],0.990294451180479
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",20951,2862,1.16 [1.10-1.23],4.113577383556121e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22237,783,1.15 [1.03-1.28],0.0135924988587665
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Left bundle-branch block,17141,515,1.07 [0.93-1.23],0.3447263969116578
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22059,1039,1.14 [1.03-1.25],0.0081493447874226
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",18983,894,1.21 [1.10-1.34],0.0001621179135595
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",22616,182,1.34 [1.09-1.66],0.0063193276019279
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",22699,397,1.15 [0.99-1.34],0.0765569646661178
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Oesophageal varices,20931,63,0.94 [0.63-1.40],0.745674151083111
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other aneurysm,21104,104,1.33 [1.00-1.77],0.0484587524885428
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other arrhythmias,17217,591,1.17 [1.03-1.33],0.0127867892963027
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,21131,131,1.35 [1.05-1.74],0.017930605917304
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21320,320,1.28 [1.09-1.51],0.0030464323721107
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,16850,224,1.11 [0.90-1.37],0.3220185734952089
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other disorders of veins,20987,119,0.97 [0.73-1.30],0.8562115095793297
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,20914,46,1.25 [0.81-1.94],0.3141322756889037
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,20721,89,0.98 [0.70-1.39],0.9310616226766694
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,21044,176,1.03 [0.81-1.31],0.8177184800427285
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,18062,1436,1.10 [1.02-1.20],0.01753131237189
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,21012,60,1.04 [0.69-1.56],0.8611762009044306
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,21724,724,1.22 [1.09-1.36],0.0004401756193402
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,21973,520,1.19 [1.04-1.36],0.0102277581851784
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",21601,969,1.11 [1.01-1.23],0.037022209675377
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,9135,412,1.16 [1.00-1.36],0.0573542836827851
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Peripheral artery disease,21554,589,1.35 [1.20-1.52],4.951126639280742e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21278,410,0.99 [0.84-1.16],0.891286220045052
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22051,598,0.95 [0.83-1.09],0.4533115915086125
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,22646,948,1.02 [0.92-1.13],0.6837326422269104
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Right bundle-branch block,17129,503,1.03 [0.89-1.18],0.7327464430655843
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Secondary right heart disease,21966,513,1.20 [1.05-1.37],0.006046085671677
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,20892,260,1.14 [0.94-1.38],0.1775629142106387
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22221,892,1.13 [1.02-1.25],0.0194683101810157
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22206,928,1.15 [1.04-1.27],0.0072470945632053
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,21442,58,1.18 [0.80-1.76],0.4067869740055944
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,21105,105,0.95 [0.69-1.30],0.7450516314459793
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Transient ischemic attack,21768,314,1.29 [1.09-1.53],0.0024428440412242
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21346,326,1.26 [1.07-1.48],0.0058979830250736
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Varicose veins,21382,514,1.12 [0.98-1.29],0.0976759948390416
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,21021,120,0.94 [0.70-1.26],0.6897822927381811
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22464,933,0.96 [0.87-1.07],0.4996314699171529
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",22661,330,0.81 [0.68-0.97],0.0249863318767387
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19419,1371,1.13 [1.04-1.23],0.0047953507473776
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Any mental disorder,22216,4168,1.13 [1.08-1.19],4.333665567582593e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",22632,389,0.83 [0.70-0.98],0.0297701031487272
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19481,1433,1.26 [1.16-1.36],1.3607323069454162e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",18132,84,1.00 [0.70-1.43],0.99441524524557
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Smoking dependency,22238,1167,1.29 [1.19-1.41],5.177201065091805e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19484,1436,1.17 [1.08-1.27],0.0001125228818055
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Vascular dementia,21848,228,0.93 [0.75-1.16],0.5275325480565556
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Alzheimer disease,22740,590,1.01 [0.88-1.15],0.9269235184913952
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",13915,111,1.32 [0.98-1.77],0.0673041702868141
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Bell's palsy,20920,84,1.06 [0.75-1.49],0.7608223777168692
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21319,483,1.18 [1.02-1.35],0.0216438332332246
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Cerebral cysts,22301,244,0.91 [0.74-1.12],0.3917370827224725
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,22669,404,0.98 [0.84-1.15],0.8502378874076805
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,21894,75,1.25 [0.89-1.76],0.2028293022878534
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,22724,67,0.82 [0.55-1.23],0.3452348474291633
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22142,85,1.04 [0.74-1.46],0.8376736519189253
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Epilepsy,21256,301,1.01 [0.84-1.21],0.9336053103241204
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22280,1325,1.12 [1.03-1.22],0.0088371677375545
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,22688,916,0.98 [0.88-1.09],0.6921773604172214
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22088,3413,1.01 [0.95-1.06],0.8196549939126456
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Generalized epilepsy,22360,52,1.10 [0.71-1.69],0.6692845906767488
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Hemiplegia,22593,328,1.11 [0.94-1.32],0.2197543896439536
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Hydrocephalus,22132,75,1.10 [0.77-1.58],0.5917976688866382
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,22727,74,1.56 [1.14-2.12],0.00530625511187
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,20902,66,1.10 [0.75-1.63],0.6123853449009188
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,20904,68,1.15 [0.79-1.67],0.4669298573336513
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Memory loss,21598,140,1.10 [0.85-1.44],0.4650819136832821
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Migraine,21227,272,1.11 [0.92-1.34],0.2608945735146213
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",22693,248,1.08 [0.88-1.31],0.4656268795198751
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Motor neuron disease,14001,175,1.03 [0.80-1.31],0.8380964390654028
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,22612,61,0.88 [0.58-1.34],0.556347206112209
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22038,1202,1.09 [0.99-1.19],0.0689827014856515
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Neurological diseases,21270,4301,1.05 [1.00-1.10],0.0598571600527629
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,22139,320,0.92 [0.77-1.10],0.3706109828810473
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21252,416,1.16 [1.00-1.35],0.0537644324513362
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",22665,344,1.24 [1.05-1.46],0.0091224675027508
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,16994,971,1.06 [0.96-1.17],0.2666672493190768
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22140,83,1.12 [0.80-1.57],0.4953515449712374
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other disorders of nervous system,22216,159,1.09 [0.85-1.40],0.4890315824639937
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,22000,228,1.04 [0.84-1.28],0.7183363241537765
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other facial nerve disorders,20930,94,1.09 [0.79-1.51],0.5856632934157254
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other headache syndromes,21008,53,1.47 [1.00-2.15],0.0488171963919242
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other neurological diseases,22630,573,1.03 [0.90-1.18],0.6533494230915302
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other sleep disorders,21465,510,1.04 [0.91-1.20],0.5626425410308311
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Parkinson's disease,22709,686,0.94 [0.83-1.06],0.3252860805501236
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22101,44,0.98 [0.61-1.60],0.9455122153933052
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Restless leg syndrome,22741,104,0.98 [0.72-1.34],0.8996693374451817
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Sleep apnoea,22511,431,1.09 [0.94-1.26],0.274760032098358
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Small fibre neuropathy,22378,57,1.09 [0.72-1.65],0.6956907229550007
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,22729,202,0.95 [0.76-1.19],0.6483163876974702
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,20904,68,0.94 [0.63-1.39],0.755679704240223
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,22740,596,1.01 [0.88-1.15],0.9014670216062528
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),21786,222,0.94 [0.75-1.17],0.556432540428387
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22114,151,1.15 [0.90-1.48],0.2694235004945876
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,22292,551,1.11 [0.97-1.27],0.1242998813321311
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22487,262,1.24 [1.03-1.49],0.0260073195923722
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,21530,67,1.03 [0.70-1.52],0.8768059001853429
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,21500,37,1.20 [0.73-1.96],0.4695301273515579
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",22620,73,1.39 [0.99-1.94],0.0555713023957983
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,22424,220,0.97 [0.78-1.21],0.7991360334506377
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2417,77,1.04 [0.71-1.50],0.8515243593011427
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2980,112,1.28 [0.95-1.71],0.1000628183226043
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22065,102,0.79 [0.57-1.11],0.1748830885291091
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22447,1401,1.10 [1.01-1.19],0.0276843725236496
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22330,867,1.02 [0.91-1.13],0.7481204627840008
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,21759,296,1.03 [0.85-1.23],0.7785005138478694
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",22668,927,1.06 [0.95-1.17],0.2996360521976176
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,22734,82,1.28 [0.92-1.76],0.1402799316367532
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,22600,859,1.06 [0.96-1.19],0.2521470960581726
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",22700,496,1.04 [0.90-1.20],0.6226043025445825
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,22623,221,1.05 [0.85-1.30],0.6208052668241161
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,21561,98,1.24 [0.92-1.68],0.154978455315732
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,21563,100,1.05 [0.77-1.44],0.7640051814275899
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,21534,71,0.93 [0.63-1.37],0.7177448421239748
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,22604,992,0.97 [0.88-1.07],0.5532826197494122
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,21867,255,0.83 [0.67-1.02],0.0737612960362461
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,21810,69,1.00 [0.68-1.47],0.9947588115363598
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,22324,120,0.91 [0.67-1.22],0.5263672170139526
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,22592,388,1.07 [0.91-1.25],0.4381510964627161
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,21957,216,0.96 [0.77-1.20],0.7358106664973803
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,22539,137,0.95 [0.72-1.25],0.6905218216204705
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22274,662,1.04 [0.92-1.18],0.5140284398171133
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22121,158,0.97 [0.75-1.25],0.7877215096274033
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20330,3202,1.05 [0.99-1.11],0.1136361819533984
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,22546,342,1.04 [0.87-1.23],0.6936833753251537
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,22730,182,1.08 [0.85-1.36],0.532498671015709
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,21991,528,1.05 [0.92-1.21],0.4452303038514614
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,22293,89,0.88 [0.62-1.25],0.4925276902972684
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,22725,73,1.32 [0.94-1.85],0.1054885525254689
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,21590,127,0.81 [0.60-1.09],0.155937914999701
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,21636,173,0.93 [0.73-1.19],0.5693340164391734
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,21209,163,1.35 [1.07-1.69],0.0101077487560008
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,21802,61,1.04 [0.70-1.56],0.8373626637073567
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",21117,71,1.11 [0.77-1.61],0.5635952074592743
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,21725,113,0.90 [0.66-1.23],0.5062100881503422
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",21899,287,0.99 [0.82-1.20],0.9489979050805104
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,21621,158,1.11 [0.87-1.42],0.4159195811096005
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,21142,96,1.23 [0.91-1.67],0.1852120677356121
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,21178,132,0.98 [0.74-1.30],0.9111743067148887
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,19823,2695,1.07 [1.01-1.14],0.0277678569095596
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,21551,88,0.97 [0.69-1.36],0.8573954168866291
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22456,493,1.02 [0.88-1.17],0.8217917625468389
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22040,77,1.22 [0.87-1.71],0.2556988826833377
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22162,199,1.15 [0.93-1.43],0.2059270318577559
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,22524,110,1.18 [0.88-1.58],0.2633546320158351
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,22697,140,1.17 [0.90-1.51],0.2342437009309536
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,22607,119,1.28 [0.98-1.67],0.0731652342903946
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,22477,63,0.76 [0.50-1.16],0.2055571485292349
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,22481,67,0.93 [0.62-1.38],0.7118589011133363
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,22633,1227,1.13 [1.03-1.23],0.0071765225344521
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,22334,928,1.12 [1.01-1.24],0.0322950011056052
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,21559,153,1.07 [0.83-1.38],0.6280951386812981
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,21492,86,1.08 [0.77-1.51],0.6726941542613918
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Acute pharyngitis,22553,65,0.95 [0.63-1.42],0.794549234447766
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,22670,182,1.10 [0.88-1.39],0.4050197030866667
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,22548,60,1.17 [0.79-1.73],0.4467328340584104
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,All influenza,20110,156,1.13 [0.88-1.44],0.3418809006163941
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),20107,153,1.13 [0.88-1.45],0.3218798750092739
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Allergic asthma (mode),14009,102,1.01 [0.73-1.39],0.961973235158924
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Allergic rhinitis,22635,232,0.90 [0.73-1.12],0.341916987696455
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15201,1673,1.04 [0.96-1.12],0.3416208683451457
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",15558,1651,1.03 [0.95-1.12],0.4369451124413795
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),22233,175,1.21 [0.97-1.52],0.095377773641816
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",20056,102,1.42 [1.08-1.88],0.0130528161188865
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Bronchiectasis,19071,507,1.18 [1.03-1.36],0.0142693084365462
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",18635,71,1.47 [1.06-2.04],0.0222311064093683
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,21627,3063,1.05 [0.99-1.11],0.074393491687371
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",21538,72,0.92 [0.63-1.35],0.6806926360699432
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Chronic sinusitis,21596,130,1.13 [0.87-1.48],0.3618637610048879
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22453,1605,1.06 [0.98-1.14],0.1461982443903912
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Deviated nasal septum,21543,77,0.83 [0.57-1.21],0.3340524833888988
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,20622,5997,1.08 [1.04-1.12],0.0002635263021554
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",21798,332,1.08 [0.91-1.28],0.3528579853170708
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Early onset COPD,20953,105,1.12 [0.84-1.51],0.4392312233197698
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Emphysema,18987,423,1.26 [1.09-1.45],0.0015219339173267
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21468,441,1.33 [1.16-1.53],4.866804158679246e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22492,2538,1.14 [1.07-1.21],3.1529528253456246e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Interstitial lung disease,21509,482,1.35 [1.19-1.54],5.834192305577384e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Later onset COPD,22226,1500,1.06 [0.97-1.14],0.1875049469975147
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,22724,490,1.13 [0.98-1.30],0.0896728095480687
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Nasal polyp,21556,90,0.87 [0.61-1.22],0.4153835952400795
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22458,1278,1.17 [1.07-1.27],0.0003607012793839
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other diseases of pleura,22454,2645,1.07 [1.01-1.14],0.0201793861469129
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22201,735,1.01 [0.90-1.13],0.8958481841845687
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other pleural conditions,19874,65,1.30 [0.91-1.88],0.1539789739715496
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,22618,575,1.37 [1.21-1.54],2.96791656483091e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,22615,1691,1.08 [1.00-1.16],0.0607066270001034
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Pleural effusion,21163,1354,1.06 [0.98-1.16],0.1639689401857557
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Pleural plaque,20057,248,1.21 [1.00-1.46],0.0546041374855027
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22206,2252,1.15 [1.08-1.23],1.746818073284846e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,22614,380,1.14 [0.97-1.34],0.1001038329461842
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Pneumothorax,19976,167,0.98 [0.77-1.25],0.8723757949059113
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Pollen allergy,22731,198,0.95 [0.76-1.20],0.6743970151563878
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Pulmonary oedema,22131,88,1.46 [1.08-1.97],0.0126601303468828
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Respiratory insufficiency,13977,70,0.90 [0.60-1.35],0.6039155856716754
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22435,1255,1.17 [1.07-1.27],0.000427666338134
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,21700,234,0.90 [0.73-1.12],0.3538048319821376
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Viral pneumonia,20252,298,1.12 [0.94-1.34],0.2008672219528882
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",22241,239,1.08 [0.88-1.32],0.4780935883402775
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,7235,119,1.29 [0.97-1.72],0.0766393659865199
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14411,59,1.46 [1.01-2.11],0.0460707421818597
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Acute appendicitis,22631,126,1.13 [0.86-1.48],0.3839860153956229
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Acute gastritis,15820,105,1.62 [1.26-2.09],0.0001776998085578
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Acute pancreatitis,20729,195,1.41 [1.15-1.72],0.000966550959245
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Acute peritonitis,22263,102,1.00 [0.73-1.37],0.9968113719196916
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Alcoholic liver disease,21781,62,0.68 [0.44-1.04],0.0762721177297311
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Barrett oesophagus,16218,503,1.09 [0.95-1.25],0.2289011608642899
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",20682,148,1.50 [1.20-1.88],0.0003976008425671
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",22329,148,1.48 [1.18-1.86],0.000685166746642
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Cholecystitis,20754,220,1.04 [0.84-1.28],0.7403198968097908
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Cholelithiasis,21569,1035,1.27 [1.16-1.39],3.216054561131916e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Chronic gastritis,16064,349,1.02 [0.86-1.21],0.7968053387400402
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Chronic pancreatitis,20590,56,0.83 [0.53-1.29],0.4002484451119734
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",22605,124,0.91 [0.68-1.21],0.5146520966349768
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Coeliac disease,21030,124,1.29 [1.00-1.68],0.0494123532610465
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Collagenous colitis,21027,101,1.17 [0.87-1.58],0.2966012559795309
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,22624,152,1.11 [0.86-1.42],0.4180183832785588
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Constipation,22457,2091,1.06 [0.99-1.14],0.0852018617559296
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Crohn disease,21013,87,1.49 [1.12-2.00],0.0070474839902528
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22397,67,1.29 [0.90-1.84],0.1597449262414836
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21005,79,1.67 [1.25-2.22],0.0004741649772097
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Dental caries,22139,184,0.95 [0.75-1.20],0.6474187701717169
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,19624,2519,1.06 [1.00-1.13],0.0644363442606804
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of appendix,22660,155,1.12 [0.87-1.43],0.3707297998581524
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of liver,22620,901,1.05 [0.95-1.17],0.3518616690134066
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20215,4500,1.06 [1.01-1.11],0.0239489371387422
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22414,459,0.95 [0.82-1.11],0.5313174539535818
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of peritoneum,22654,493,1.08 [0.94-1.24],0.2860726340700067
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22045,90,0.75 [0.52-1.06],0.1058007196609303
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of salivary glands,21923,58,1.12 [0.75-1.68],0.574565919757128
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22407,1501,1.07 [0.99-1.16],0.088556576324674
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of tongue,21940,94,1.07 [0.77-1.48],0.6890742707513913
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22034,1500,1.20 [1.11-1.30],3.261761554113149e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,18082,3730,1.06 [1.01-1.12],0.0236695723295234
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Duodenal ulcer,15960,245,1.22 [1.01-1.49],0.0399749079915909
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",22648,200,1.28 [1.04-1.57],0.0219965083134107
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,22707,27,1.56 [0.93-2.60],0.0895951889709392
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,21865,146,0.94 [0.72-1.22],0.6379716665920219
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14456,104,1.12 [0.82-1.52],0.4885503276169166
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Functional dyspepsia,16275,560,1.14 [1.00-1.30],0.0457408948517191
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastric ulcer,16141,426,1.15 [0.99-1.33],0.0745523700547783
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18327,2612,1.03 [0.97-1.10],0.319287915290487
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,16363,648,1.12 [0.99-1.27],0.0652248669398897
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16417,8063,1.05 [1.01-1.09],0.0083735163320065
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,GI-bleeding,22153,1247,1.06 [0.97-1.16],0.1809369085863175
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,21999,44,0.95 [0.58-1.54],0.8205278668845545
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,15323,1158,1.01 [0.92-1.11],0.8090712234587739
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",21785,66,0.80 [0.53-1.20],0.2718293409317104
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Hernia,20709,3604,1.05 [0.99-1.11],0.0787097686893307
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Impacted teeth,22711,25,1.73 [1.05-2.84],0.0300150298567373
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Impaction of intestines,14431,79,1.30 [0.93-1.82],0.1245936203153021
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Inguinal hernia,18191,1086,1.04 [0.95-1.15],0.3802102200809087
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",17225,120,1.00 [0.74-1.34],0.986867328805031
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,14466,114,1.02 [0.76-1.38],0.8741510211767284
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21049,143,1.28 [1.00-1.62],0.049164898411777
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,14858,506,1.06 [0.92-1.22],0.4418758979819628
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,22708,331,1.23 [1.05-1.45],0.0128889004108533
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,21701,775,1.23 [1.10-1.37],0.0001512590227036
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22000,1074,1.18 [1.07-1.29],0.0005438903815914
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Oesophageal obstruction,15933,218,0.98 [0.78-1.21],0.8239239586096538
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Oesophagitis,16405,690,1.08 [0.96-1.22],0.2050757681031647
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,22686,135,0.98 [0.74-1.28],0.8645067687631891
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,17192,87,0.89 [0.63-1.28],0.5364270816406475
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15704,1352,1.11 [1.02-1.21],0.0161351748169824
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,20892,358,1.20 [1.02-1.41],0.0236854218589412
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,20674,140,1.17 [0.90-1.52],0.2300728454449238
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of intestine,16256,1904,1.10 [1.02-1.18],0.0120358931672145
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of intestines,20461,6109,1.06 [1.02-1.10],0.0058609990040936
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,21899,211,1.04 [0.84-1.29],0.7234912754306326
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of liver,22464,745,1.08 [0.96-1.21],0.1793427200658302
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,16469,754,1.12 [1.00-1.25],0.052368044352151
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of pancreas,20747,213,1.20 [0.98-1.48],0.0818216775612328
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,22582,421,1.06 [0.91-1.23],0.4791789164600468
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,16786,1071,1.08 [0.98-1.19],0.1011090590507085
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22169,1263,1.07 [0.98-1.16],0.1607737734648171
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22122,167,0.89 [0.69-1.14],0.35354258625814
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,16487,2135,1.08 [1.01-1.15],0.0329321780909855
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),17838,2123,1.11 [1.04-1.19],0.0017415325411043
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,21828,109,0.95 [0.70-1.29],0.7419975819843896
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,21871,945,1.20 [1.09-1.32],0.0003223169360969
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",14791,439,1.12 [0.96-1.30],0.1399667483264083
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,22703,30,1.52 [0.93-2.49],0.0955418550254024
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,14960,608,1.04 [0.91-1.18],0.5582253065096999
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21059,153,0.99 [0.77-1.29],0.9642525374738924
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Recurring oral aphthae,22731,49,1.07 [0.68-1.67],0.7655212643295108
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,21951,99,1.24 [0.92-1.67],0.1515446947803893
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Toxic colitis,21004,78,0.95 [0.66-1.37],0.7712380187728357
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,16048,333,1.12 [0.95-1.33],0.1894787118367947
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Ulcerative colitis,21093,167,1.18 [0.94-1.50],0.1593431073538109
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21061,135,1.12 [0.86-1.46],0.3904599278584703
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Umbilical hernia,17360,255,1.00 [0.81-1.22],0.972697465951812
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,14588,236,1.13 [0.92-1.39],0.2372060809543543
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Ventral hernia,17396,291,1.06 [0.88-1.27],0.565816456059341
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Volvulus,14446,94,0.69 [0.48-0.98],0.0370271953727502
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,22637,410,0.88 [0.75-1.04],0.1397177596695013
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,22385,65,1.61 [1.17-2.22],0.0037213040693396
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,20229,158,0.98 [0.76-1.26],0.860296847547791
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22123,805,1.05 [0.94-1.17],0.4298356160537089
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21455,137,1.13 [0.87-1.47],0.3590031326686165
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,20689,618,1.11 [0.98-1.26],0.0895231395407289
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,22408,315,1.13 [0.95-1.34],0.1760481691731143
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,22646,553,1.14 [1.00-1.30],0.0549212122622264
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22140,47,1.64 [1.12-2.39],0.010767278491969
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21170,3666,1.04 [0.99-1.10],0.1252934819054269
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22309,436,1.11 [0.96-1.29],0.173868316282858
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22179,306,1.15 [0.96-1.37],0.1192687199626788
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22364,1046,1.05 [0.95-1.16],0.3355455815384862
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",22721,61,1.16 [0.78-1.71],0.4686744336152815
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,20127,56,0.61 [0.38-0.96],0.0339000009544152
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,21934,61,0.85 [0.56-1.30],0.4484590172348718
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,22395,302,1.13 [0.95-1.35],0.1719017117778249
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,20662,591,0.97 [0.85-1.11],0.7083857085782335
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,20158,87,1.20 [0.87-1.66],0.2657514252485765
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,22655,93,0.97 [0.69-1.35],0.8529028860309837
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,21553,235,1.16 [0.95-1.42],0.133919299034062
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,22539,219,0.97 [0.78-1.20],0.7731053292314796
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22186,93,1.20 [0.88-1.64],0.2540053353686085
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,20148,77,1.10 [0.77-1.57],0.6038845096185355
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22142,2071,1.03 [0.96-1.11],0.3754418989506669
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",20706,635,0.98 [0.86-1.11],0.7087427688109256
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,20162,91,1.13 [0.82-1.56],0.4516726879681382
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,22652,332,1.07 [0.90-1.27],0.4250188632321705
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,22166,73,0.98 [0.67-1.42],0.8957997146073645
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,22590,270,1.05 [0.86-1.27],0.6378455118348331
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,22669,442,0.86 [0.73-1.01],0.06048157025767
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,20189,118,1.04 [0.77-1.39],0.810300428010395
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,20410,339,0.85 [0.71-1.01],0.0686282248832743
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,22657,430,0.86 [0.73-1.01],0.0640514772015378
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",20397,326,1.24 [1.06-1.46],0.0089297720866358
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,22713,151,1.03 [0.80-1.33],0.8136766766514265
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,18941,76,0.96 [0.66-1.39],0.82123914825596
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,20034,6332,1.05 [1.01-1.10],0.0128172489688479
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,18645,4943,1.06 [1.01-1.11],0.0165653605616075
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,18917,52,1.35 [0.90-2.02],0.1484697826007265
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,18845,144,0.94 [0.72-1.23],0.6499519434036591
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,18889,188,0.89 [0.70-1.13],0.3426653321047029
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,22484,63,0.90 [0.59-1.36],0.6103323088167293
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",18853,152,1.08 [0.83-1.39],0.5734614060108498
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,15155,1453,1.01 [0.92-1.09],0.8993617702845139
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",22528,240,0.90 [0.73-1.11],0.3322883598957603
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,19280,579,0.99 [0.87-1.14],0.9334329330454604
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18391,7908,1.04 [1.00-1.07],0.0565789974197499
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20233,115,1.02 [0.75-1.37],0.9130569900914935
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,19044,179,1.07 [0.85-1.35],0.5686821502372742
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,19363,498,1.07 [0.93-1.23],0.3537142404572915
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,21810,3109,1.02 [0.97-1.08],0.4250341717657501
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19168,303,0.83 [0.68-1.00],0.0532408503634792
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,19009,144,1.27 [0.99-1.63],0.0570560126612614
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,18982,117,0.95 [0.71-1.29],0.7545736875745161
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22011,97,0.93 [0.67-1.30],0.6738343618844729
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,15683,1981,1.05 [0.98-1.13],0.1543617480322489
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14487,785,1.20 [1.07-1.34],0.0012551724118734
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",22644,778,1.16 [1.04-1.29],0.0066699759734102
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,13777,75,0.81 [0.55-1.20],0.2883814657918802
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),13996,294,1.13 [0.94-1.36],0.1919746169131845
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,19127,262,1.07 [0.88-1.30],0.5159947156146317
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14174,472,1.04 [0.90-1.21],0.5908876882983041
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,18783,82,1.07 [0.76-1.52],0.6860287017922074
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,19383,682,1.06 [0.94-1.19],0.3827202445515735
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,19013,312,1.13 [0.95-1.35],0.1623652501729601
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14146,444,1.05 [0.90-1.22],0.5333985714923972
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,18936,71,0.95 [0.65-1.40],0.8043030694793895
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",18925,60,1.23 [0.83-1.82],0.2953196821354317
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,20204,86,1.16 [0.84-1.61],0.3588143033422445
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22313,2195,0.95 [0.89-1.02],0.1337747781217075
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,21664,1546,0.98 [0.90-1.06],0.5721414942822949
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",22569,530,1.13 [0.99-1.30],0.0652372749776692
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,16777,3075,1.10 [1.04-1.16],0.0009590388324667
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,13745,43,1.00 [0.61-1.63],0.9891068032276216
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,18971,106,1.10 [0.81-1.49],0.5440357596628955
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,13769,67,1.40 [0.97-2.02],0.069681601032359
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),13833,131,0.91 [0.68-1.22],0.5362271133838826
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,20354,236,0.90 [0.73-1.12],0.3445015662222831
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,20619,501,0.87 [0.75-1.01],0.0770744021669731
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,22718,109,1.19 [0.89-1.59],0.2391819172226306
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",20663,1962,1.03 [0.96-1.11],0.392736859517106
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,18937,72,1.81 [1.37-2.40],3.188983468206677e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),13853,151,0.96 [0.74-1.26],0.7922831785117497
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,19475,774,1.06 [0.94-1.19],0.3337377361777024
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,15856,2154,1.03 [0.96-1.10],0.4066005762379409
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22035,121,1.03 [0.77-1.37],0.8379943322974265
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,22729,62,1.60 [1.15-2.23],0.0051599875755462
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,18942,77,0.89 [0.61-1.29],0.5389085687806795
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20196,1331,1.13 [1.04-1.23],0.0044233193646329
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,18970,105,0.93 [0.68-1.28],0.6712277012151433
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,15747,2045,1.10 [1.03-1.18],0.0050861268986714
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20232,114,0.88 [0.64-1.20],0.4099032486873454
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,18903,38,1.30 [0.80-2.10],0.2832702219191437
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,18892,191,0.77 [0.61-0.99],0.0378592228154018
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,19543,678,1.08 [0.96-1.22],0.1964801744609372
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22395,481,1.03 [0.89-1.19],0.7262384698944404
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,19356,655,1.05 [0.93-1.19],0.4140278743287365
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,22584,524,1.12 [0.98-1.28],0.1095697772224328
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,22715,67,1.59 [1.16-2.19],0.0042889811688202
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,19025,160,1.13 [0.88-1.44],0.3353145096191448
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17679,879,1.09 [0.98-1.21],0.1191349764029992
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,19499,634,1.19 [1.05-1.34],0.0059158554533829
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19138,273,0.84 [0.69-1.03],0.0981418896120738
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",13772,70,1.18 [0.82-1.71],0.3734982585679564
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16777,3075,1.14 [1.08-1.20],5.873577571299237e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14520,818,1.21 [1.09-1.35],0.0003989101860586
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22283,369,1.00 [0.85-1.19],0.9848067420671532
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",22688,79,1.13 [0.80-1.60],0.4827562623992146
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",20120,67,1.06 [0.72-1.54],0.7803669181855698
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,13765,63,1.62 [1.16-2.26],0.0049343679190494
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,18809,108,1.14 [0.85-1.54],0.3744823943750152
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14240,538,1.19 [1.04-1.36],0.0103183187035617
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19197,332,0.99 [0.83-1.18],0.92672588887125
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,18986,285,1.25 [1.05-1.49],0.0140113972029234
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,18968,267,1.02 [0.84-1.24],0.8377376280619424
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,15976,67,1.20 [0.83-1.74],0.3371039279824234
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",22720,72,1.56 [1.14-2.13],0.0051303932100021
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,19410,545,0.98 [0.86-1.13],0.8241721467873885
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],22003,89,1.13 [0.81-1.56],0.4747920933796608
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21462,2597,1.05 [0.99-1.12],0.0961297487650439
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",19011,146,0.96 [0.74-1.26],0.7771819595178101
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,19402,701,0.99 [0.88-1.12],0.9341438432809208
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,21401,268,0.78 [0.63-0.95],0.0160759352467385
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,18949,248,0.98 [0.80-1.20],0.8343463372284505
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,20677,1976,1.01 [0.94-1.08],0.8115441164616842
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,19995,1294,1.06 [0.97-1.16],0.2001778358003468
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],18928,63,1.01 [0.67-1.51],0.9703532523828146
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22027,113,0.88 [0.64-1.19],0.4024397045122666
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,19023,158,1.10 [0.86-1.40],0.4684505791418923
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,18954,89,1.00 [0.71-1.40],0.9820647686621646
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),13779,77,1.11 [0.78-1.60],0.5544748511905677
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Acute renal failure,21252,2220,1.22 [1.14-1.30],2.2195031240649912e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9088,25,0.96 [0.50-1.84],0.9054738234071956
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,11536,33,0.53 [0.29-0.98],0.0413550908098546
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22411,312,1.12 [0.94-1.34],0.1915683725256201
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22205,106,1.25 [0.94-1.67],0.1247308687552624
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21333,2301,1.25 [1.17-1.33],5.403718737891424e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,22511,131,1.64 [1.30-2.07],2.5893011000265624e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,22437,398,1.18 [1.01-1.37],0.0360194665178122
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Cystitis,18951,295,1.02 [0.85-1.23],0.8082051944827472
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Dialysis,19127,95,1.95 [1.52-2.50],1.1689564478527565e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10029,2107,1.08 [1.00-1.15],0.0382968883537872
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Disorders of breast,11637,134,0.83 [0.62-1.11],0.2082552066105606
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Endometriosis,9102,39,0.99 [0.59-1.65],0.957278104094499
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9636,573,1.04 [0.91-1.19],0.5253204376015461
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18719,6189,1.08 [1.04-1.12],0.0001696417260438
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,22476,96,1.37 [1.02-1.84],0.0384505362970674
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Hydrocele,8040,118,0.94 [0.70-1.27],0.6897869662386944
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,19101,347,1.19 [1.01-1.41],0.0338581939657148
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9719,1797,1.08 [1.00-1.17],0.0370665312113816
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,11701,160,0.95 [0.73-1.22],0.6829538562782207
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),8045,123,1.04 [0.78-1.38],0.7926686656745476
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,18741,85,1.30 [0.95-1.79],0.1021798760016958
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10085,1022,0.99 [0.89-1.09],0.8336094220662148
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,7981,59,1.23 [0.83-1.83],0.2968110173777279
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9102,39,0.51 [0.29-0.89],0.0185279962492453
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",22726,85,1.05 [0.74-1.48],0.7873222568116679
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",22727,81,0.83 [0.57-1.20],0.3227414500157703
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,21560,2904,1.08 [1.02-1.15],0.0084132483932032
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,19587,931,1.11 [1.00-1.23],0.0419386368217752
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,11554,51,0.81 [0.51-1.29],0.3687330268312079
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,22659,620,1.27 [1.13-1.44],5.889082118891487e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,8073,151,1.27 [0.99-1.62],0.0578121682097934
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,8084,162,1.22 [0.96-1.55],0.1042657956494668
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,8073,151,0.97 [0.74-1.26],0.794000004343894
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,22702,87,0.95 [0.67-1.35],0.7817032294137535
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,20959,2303,1.11 [1.04-1.18],0.0023055531749764
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,11624,83,1.02 [0.72-1.44],0.9328984701430932
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9128,65,1.08 [0.73-1.59],0.7116702324376833
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9202,139,1.16 [0.89-1.50],0.2677402768977267
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9115,52,1.34 [0.90-1.99],0.1464621356223384
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9160,97,0.95 [0.69-1.32],0.7695871069719286
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,19162,408,1.25 [1.08-1.45],0.0030466345016223
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,22237,198,1.33 [1.08-1.64],0.006205051108229
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9188,125,0.84 [0.62-1.13],0.2492266101534887
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9088,25,0.99 [0.52-1.88],0.9720214652100676
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9272,209,0.83 [0.66-1.05],0.1222995511550153
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9157,94,1.43 [1.07-1.90],0.0145565797812353
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9266,203,0.86 [0.69-1.09],0.2179021714631504
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,22424,44,1.17 [0.74-1.83],0.5004755256288927
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",8076,154,1.13 [0.88-1.45],0.3359629629084731
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22455,3701,1.19 [1.13-1.25],2.9058593037624888e-11
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",18848,94,1.15 [0.84-1.59],0.3753162204218941
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,19210,178,1.30 [1.05-1.62],0.0183267132903834
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22138,39,1.49 [0.96-2.31],0.0772033871756774
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Urethral stricture,18918,262,1.09 [0.90-1.32],0.3876019104443378
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Urolithiasis,22497,398,1.15 [0.98-1.34],0.0783316868081818
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9098,35,1.03 [0.60-1.77],0.9041637781585056
